Skip to content

Landmark ruling deems cancer gene patents invalid

“A district court judge in the United States has ruled that patents should not have been awarded over the breast and ovarian cancer genes BRCA1 and 2. The decision raises serious concerns about whether patents should be awarded on human and other genes and proteins found in nature.” Click here to read more at ABC Online.

Subscribe to our weekly e-Bulletin.

Like to receive AFMW news direct to your email? Please enter your details below to join our list. Please note subscribing to our mailing list does not confer AFMW membership.

* indicates required